vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and INTERFACE INC (TILE). Click either name above to swap in a different company.
INTERFACE INC is the larger business by last-quarter revenue ($349.4M vs $284.0M, roughly 1.2× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 7.0%, a 89.4% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 4.3%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 9.8%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
ACAD vs TILE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $349.4M |
| Net Profit | $273.6M | $24.4M |
| Gross Margin | 90.8% | 38.6% |
| Operating Margin | 6.1% | 10.1% |
| Net Margin | 96.3% | 7.0% |
| Revenue YoY | 9.4% | 4.3% |
| Net Profit YoY | 90.3% | 12.1% |
| EPS (diluted) | $1.61 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $349.4M | ||
| Q3 25 | $278.6M | $364.5M | ||
| Q2 25 | $264.6M | $375.5M | ||
| Q1 25 | $244.3M | $297.4M | ||
| Q4 24 | $259.6M | $335.0M | ||
| Q3 24 | $250.4M | $344.3M | ||
| Q2 24 | $242.0M | $346.6M | ||
| Q1 24 | $205.8M | $289.7M |
| Q4 25 | $273.6M | $24.4M | ||
| Q3 25 | $71.8M | $46.1M | ||
| Q2 25 | $26.7M | $32.6M | ||
| Q1 25 | $19.0M | $13.0M | ||
| Q4 24 | $143.7M | $21.8M | ||
| Q3 24 | $32.8M | $28.4M | ||
| Q2 24 | $33.4M | $22.6M | ||
| Q1 24 | $16.6M | $14.2M |
| Q4 25 | 90.8% | 38.6% | ||
| Q3 25 | 92.2% | 39.4% | ||
| Q2 25 | 92.2% | 39.4% | ||
| Q1 25 | 91.7% | 37.3% | ||
| Q4 24 | 91.6% | 36.5% | ||
| Q3 24 | 92.5% | 37.1% | ||
| Q2 24 | 92.5% | 35.4% | ||
| Q1 24 | 88.8% | 38.1% |
| Q4 25 | 6.1% | 10.1% | ||
| Q3 25 | 12.8% | 14.6% | ||
| Q2 25 | 12.2% | 13.9% | ||
| Q1 25 | 7.9% | 7.8% | ||
| Q4 24 | 59.1% | 8.8% | ||
| Q3 24 | 12.6% | 12.3% | ||
| Q2 24 | 12.6% | 11.0% | ||
| Q1 24 | 7.4% | 8.4% |
| Q4 25 | 96.3% | 7.0% | ||
| Q3 25 | 25.8% | 12.7% | ||
| Q2 25 | 10.1% | 8.7% | ||
| Q1 25 | 7.8% | 4.4% | ||
| Q4 24 | 55.4% | 6.5% | ||
| Q3 24 | 13.1% | 8.3% | ||
| Q2 24 | 13.8% | 6.5% | ||
| Q1 24 | 8.0% | 4.9% |
| Q4 25 | $1.61 | $0.41 | ||
| Q3 25 | $0.42 | $0.78 | ||
| Q2 25 | $0.16 | $0.55 | ||
| Q1 25 | $0.11 | $0.22 | ||
| Q4 24 | $0.86 | $0.38 | ||
| Q3 24 | $0.20 | $0.48 | ||
| Q2 24 | $0.20 | $0.38 | ||
| Q1 24 | $0.10 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $71.3M |
| Total DebtLower is stronger | — | $181.6M |
| Stockholders' EquityBook value | $1.2B | $640.7M |
| Total Assets | $1.6B | $1.2B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $71.3M | ||
| Q3 25 | $258.0M | $187.4M | ||
| Q2 25 | $253.6M | $121.7M | ||
| Q1 25 | $217.7M | $97.8M | ||
| Q4 24 | $319.6M | $99.2M | ||
| Q3 24 | $155.1M | $115.6M | ||
| Q2 24 | $177.1M | $94.2M | ||
| Q1 24 | $204.7M | $89.8M |
| Q4 25 | — | $181.6M | ||
| Q3 25 | — | $307.8M | ||
| Q2 25 | — | $304.4M | ||
| Q1 25 | — | $302.9M | ||
| Q4 24 | — | $302.8M | ||
| Q3 24 | — | $337.9M | ||
| Q2 24 | — | $387.6M | ||
| Q1 24 | — | $391.8M |
| Q4 25 | $1.2B | $640.7M | ||
| Q3 25 | $917.3M | $621.0M | ||
| Q2 25 | $822.4M | $575.0M | ||
| Q1 25 | $765.2M | $513.1M | ||
| Q4 24 | $732.8M | $489.1M | ||
| Q3 24 | $577.2M | $501.6M | ||
| Q2 24 | $516.7M | $451.2M | ||
| Q1 24 | $464.0M | $428.5M |
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $976.9M | $1.2B | ||
| Q2 24 | $914.1M | $1.2B | ||
| Q1 24 | $855.1M | $1.2B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | 0.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $49.3M |
| Free Cash FlowOCF − Capex | — | $28.6M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 5.9% |
| Cash ConversionOCF / Net Profit | -0.18× | 2.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $121.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $49.3M | ||
| Q3 25 | $74.3M | $76.7M | ||
| Q2 25 | $64.0M | $30.1M | ||
| Q1 25 | $20.3M | $11.7M | ||
| Q4 24 | $40.4M | $38.0M | ||
| Q3 24 | $63.2M | $76.2M | ||
| Q2 24 | $25.0M | $21.5M | ||
| Q1 24 | $29.1M | $12.6M |
| Q4 25 | — | $28.6M | ||
| Q3 25 | $73.9M | $66.1M | ||
| Q2 25 | — | $22.8M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $24.4M | ||
| Q3 24 | $63.2M | $69.7M | ||
| Q2 24 | — | $12.0M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | 26.5% | 18.1% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | 25.2% | 20.3% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | 5.9% | ||
| Q3 25 | 0.1% | 2.9% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | 0.0% | 1.9% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | -0.18× | 2.02× | ||
| Q3 25 | 1.03× | 1.66× | ||
| Q2 25 | 2.40× | 0.93× | ||
| Q1 25 | 1.07× | 0.90× | ||
| Q4 24 | 0.28× | 1.75× | ||
| Q3 24 | 1.93× | 2.68× | ||
| Q2 24 | 0.75× | 0.95× | ||
| Q1 24 | 1.76× | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |
